MENU
GANX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Gain Therapeutics (GANX) Earnings Date & Reports
Gain Therapeutics Inc is a clinical-stage biotechnology company developing novel small-molecule therapeutics to treat diseases across several therapeutic areas, including central nervous system (CNS) disorders, lysosomal storage disorders (LSDs), metabolic disorders, and other diseases that can be targeted through protein degradation, such as oncology... Show more
A.I. Advisor
published Earnings
GANX is expected to report earnings to rise 18.18% to -12 cents per share on November 11
Q3'26
Est.
$-0.13
Q2'26
Beat
by $0.03
Q1'26
Beat
by $0.01
Q4'25
Beat
by $0.03
Q3'25
Est.
$-0.15
The last earnings report on August 11 showed earnings per share of -10 cents, beating the estimate of -14 cents. With 288.80K shares outstanding, the current market capitalization sits at 51.06M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Interesting Articles
Are Social Security Benefits Taxed?
What is the Income of the Average American?
What are the advantages and disadvantages of Automated Trading Systems?
What is the role of quants, and how has their role evolved over time?
What Were the Causes and Consequences of the Stock Market Crash of 1929 and the Great Depression?
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Industry
N/A
Address
4800 Montgomery Lane
Phone
+1 301 500-1556
Employees
21
Web
https://www.gaintherapeutics.com